Narcolepsy Type 1: Should We Only Target Hypocretin Receptor 2?
Nearly 25 years have passed since the ground-breaking discovery that hypocretin deficiency underlies human narcolepsy with cataplexy. Over time, it has become increasingly evident that hypocretin deficiency goes beyond the conventional core symptoms, or pentad, traditionally associated with narcolep...
Furkejuvvon:
| Váldodahkkit: | , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
MDPI AG
2023-09-01
|
| Ráidu: | Clinical and Translational Neuroscience |
| Fáttát: | |
| Liŋkkat: | https://www.mdpi.com/2514-183X/7/3/28 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|